Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe-city, Hyogo, 650-0017, Japan.
Langenbecks Arch Surg. 2022 Feb;407(1):105-112. doi: 10.1007/s00423-021-02302-w. Epub 2021 Aug 30.
We conducted a prospective clinical control study to identify the best imaging technology among three-dimensional (3-D) high-definition (HD) stereovision and two-dimensional (2-D) ultra-high-resolution (4 K) technology and confirm their effects on surgical outcomes of laparoscopic gastrectomy for gastric cancer.
From April 2018 to August 2019, 50 patients were randomly classified into two groups based on the imaging technology (3-D/HD group = 25, 2-D/4 K = 25). After excluding eight patients based on laparoscopic findings, 42 patients were analyzed (3-D/HD group = 21, 2-D/4 K = 21). The primary endpoint was the operative time; the secondary endpoints were blood loss, postoperative infectious complications, and postoperative hospital stay.
The patients' backgrounds were similar (sex, age, body mass index [BMI], stage, procedure, and extent of lymph node dissection). There were no significant differences in operative time (252 vs. 238 min, P = 0.70), total blood loss, postoperative infectious complications, and postoperative hospital stay between the two groups. However, video analysis of surgeries revealed a significantly shortened median operative time (18 vs. 25 min, P = 0.04) in the suturing step with 3-D/HD; the median number of camera cleaning procedures during suprapancreatic lymph node dissection was significantly lower with 2-D/4 K than with 3-D/HD (n = 4.4 vs. 2.8, P = 0.02).
3-D/HD and 2-D/4 K laparoscopic radical gastrectomies provide similar surgical outcomes. However, the 3-D monitor reduces suturing time during reconstruction, while the 4 K monitor reduces the number of camera cleaning procedures during lymphadenectomy.
Registered in the University Hospital Medical Information Network Clinical Trials Registry (identification number 000029227).
我们进行了一项前瞻性临床对照研究,旨在确定三维(3-D)高清(HD)立体视觉和二维(2-D)超高分辨率(4K)技术中哪种成像技术最佳,并确认其对腹腔镜胃癌根治术手术结果的影响。
2018 年 4 月至 2019 年 8 月,根据成像技术将 50 例患者随机分为两组(3-D/HD 组=25 例,2-D/4K 组=25 例)。排除腹腔镜检查结果后,共有 42 例患者被纳入分析(3-D/HD 组=21 例,2-D/4K 组=21 例)。主要终点为手术时间;次要终点为出血量、术后感染性并发症和术后住院时间。
患者背景相似(性别、年龄、体重指数[BMI]、分期、手术方式和淋巴结清扫范围)。两组手术时间(252 与 238min,P=0.70)、总出血量、术后感染性并发症和术后住院时间无显著差异。然而,对手术过程的视频分析显示,3-D/HD 组缝合步骤的中位手术时间明显缩短(18 与 25min,P=0.04);2-D/4K 组胰上区淋巴结清扫过程中摄像仪清洗次数中位数明显少于 3-D/HD 组(n=4.4 与 2.8,P=0.02)。
3-D/HD 和 2-D/4K 腹腔镜胃癌根治术可获得相似的手术结果。然而,3-D 显示器可减少重建过程中的缝合时间,而 4K 显示器可减少淋巴结清扫过程中的摄像仪清洗次数。
该研究已在大学医院医疗信息网络临床试验注册中心注册(注册号 000029227)。